| Literature DB >> 12240910 |
F Broglio1, F Boutignon, A Benso, C Gottero, F Prodam, E Arvat, C Ghè, F Catapano, A Torsello, V Locatelli, G Muccioli, D Boeglin, V Guerlavais, J A Fehrentz, J Martinez, E Ghigo, R Deghenghi.
Abstract
EP1572 UMV1843 [Aib-DTrp-DgTrp-CHO]) is a new peptido-mimetic GH secretagogue (GHS) showing binding potency to the GHS-receptor in animal and human tissues similar to that of ghrelin and peptidyl GHS. EP1572 induces marked GH increase after s.c. administration in neonatal rats. Preliminary data in 2 normal young men show that: 1) acute i.v. EP1572 administration (1.0 microg/kg) induces strong and selective increase of GH levels; 2) single oral EP1572 administration strongly and reproducibly increases GH levels even after a dose as low as 0.06 mg/kg. Thus, EP1572 is a new peptido-mimetic GHS with potent and selective GH-releasing activity.Entities:
Mesh：
Substances：
Year: 2002 PMID： 12240910 DOI： 10.1007/BF03345096
Source DB: PubMed Journal: J Endocrinol Invest ISSN： 0391-4097 Impact factor: 4.256